[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:partial-lipodystrophy":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Partial Lipodystrophy",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05470504","Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance",[11],"Phase 2","RECRUITING","2026-08-26T02:16:13.426928Z","2026-05-05T02:43:26.678175Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT02325674","MEASuRE: Metreleptin Effectiveness And Safety Registry",[],"2026-08-26T02:18:41.390601Z","2026-05-13T02:55:06.091911Z",[],[]]